A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

Constantinos O’Mahony(University College Hospital at Westmoreland Street), Fatima Jichi(University College London), Menelaos Pavlou(University College London), Lorenzo Monserrat(Universidade da Coruña), Aristides Anastasakis(National and Kapodistrian University of Athens), Claudio Rapezzi(University of Bologna), Elena Biagini(University of Bologna), Juan R. Gimeno(Hospital Universitario Virgen de la Arrixaca), Giuseppe Limongelli(University of Campania "Luigi Vanvitelli"), William J. McKenna(University College Hospital at Westmoreland Street), Rumana Omar(University College London), Perry Elliott(University College Hospital at Westmoreland Street), for the Hypertrophic Cardiomyopathy Outcomes Investigators
European Heart Journal
October 14, 2013
Cited by 1,211Open Access
Full Text

Abstract

AIMS: Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death (SCD) in young adults. Current risk algorithms provide only a crude estimate of risk and fail to account for the different effect size of individual risk factors. The aim of this study was to develop and validate a new SCD risk prediction model that provides individualized risk estimates. METHODS AND RESULTS: The prognostic model was derived from a retrospective, multi-centre longitudinal cohort study. The model was developed from the entire data set using the Cox proportional hazards model and internally validated using bootstrapping. The cohort consisted of 3675 consecutive patients from six centres. During a follow-up period of 24 313 patient-years (median 5.7 years), 198 patients (5%) died suddenly or had an appropriate implantable cardioverter defibrillator (ICD) shock. Of eight pre-specified predictors, age, maximal left ventricular wall thickness, left atrial diameter, left ventricular outflow tract gradient, family history of SCD, non-sustained ventricular tachycardia, and unexplained syncope were associated with SCD/appropriate ICD shock at the 15% significance level. These predictors were included in the final model to estimate individual probabilities of SCD at 5 years. The calibration slope was 0.91 (95% CI: 0.74, 1.08), C-index was 0.70 (95% CI: 0.68, 0.72), and D-statistic was 1.07 (95% CI: 0.81, 1.32). For every 16 ICDs implanted in patients with ≥4% 5-year SCD risk, potentially 1 patient will be saved from SCD at 5 years. A second model with the data set split into independent development and validation cohorts had very similar estimates of coefficients and performance when externally validated. CONCLUSION: This is the first validated SCD risk prediction model for patients with HCM and provides accurate individualized estimates for the probability of SCD using readily collected clinical parameters.


Related Papers

No related papers found

Powered by citation graph analysis